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Abstract Alterations in Ca2+ homeostasis and accumulation of
unfolded proteins in the endoplasmic reticulum (ER) lead to an
ER stress response. Prolonged ER stress may lead to cell death.
Glucose-regulated protein (GRP) 78 (Bip) is an ER lumen
protein whose expression is induced during ER stress. GRP78 is
involved in polypeptide translocation across the ER membrane,
and also acts as an apoptotic regulator by protecting the host cell
against ER stress-induced cell death, although the mechanism by
which GRP78 exerts its cytoprotective effect is not understood.
The present study was carried out to determine whether one of
the mechanisms of cell death inhibition by GRP78 involves
inhibition of caspase activation. Our studies indicate that
treatment of cells with ER stress inducers causes GRP78 to
redistribute from the ER lumen with subpopulations existing in
the cytosol and as an ER transmembrane protein. GRP78
inhibits cytochrome c-mediated caspase activation in a cell-free
system, and expression of GRP78 blocks both caspase
activation and caspase-mediated cell death. GRP78 forms a
complex with caspase-7 and -12 and prevents release of caspase-
12 from the ER. Addition of (d)ATP dissociates this complex
and may facilitate movement of caspase-12 into the cytoplasm
to set in motion the cytosolic component of the ER stress-
induced apoptotic cascade. These results define a novel
protective role for GRP78 in preventing ER stress-induced cell
death. ß 2002 Published by Elsevier Science B.V. on behalf of
the Federation of European Biochemical Societies.
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1. Introduction
Alterations in Ca2 homeostasis and accumulation of un-
folded proteins in the endoplasmic reticulum (ER) elicit cel-
lular stress responses, particularly ER stress signals, to protect
cells against changes in Ca2 levels and toxic buildup of mis-
folded proteins [1^3]. Prolonged ER stress leads to cell death
and is linked to the pathogenesis of some neurodegenerative
disorders that feature misfolded proteins including Alzhei-
mer’s disease, Parkinson’s disease and ALS [1,2]. Cells from
all organisms increase the expression of a class of ER stress
proteins in response to ER stress which serve as molecular
chaperones and are involved in protein translocation, protein
folding and assembly, and the regulation of protein secretion
[3]. Glucose-regulated protein (GRP) 78 is an ER chaperone
protein whose expression is induced during oxidative stress,
chemical toxicity, treatment with Ca2 ionophores and inhib-
itors of glycosylation [3]. This induction, which is part of the
unfolded protein response (UPR), is required to alleviate ER
stress, maintain ER function, facilitate protein folding and
thus protect cells from the aforementioned toxic insults [3,4].
Several reports suggest that GRP78 may protect the host cell
against cell death by suppressing oxyradical accumulation and
stabilizing mitochondrial function [5^8]. However, the mech-
anism by which GRP78 inhibits the ER stress-induced cell
death program, and by which this is reversed during pro-
longed ER stress leading to cell death, is still unknown.
Caspases comprise a family of cysteine-dependent aspar-
tate-directed proteases expressed in a variety of cell types
and tissues. Activation of caspases is a central mechanism in
the apoptotic cell death process [9], which may occur either
through recruitment into activating complexes or by a direct
cleavage by another caspase [9^11]. Earlier studies demon-
strated the association of caspase-7 and caspase-12 with the
ER compartment [12^16]. Caspase-12 is activated by ER
stress signals and participates in ER stress-induced apoptosis
[14^16]. The present study was performed to determine
whether one of the mechanisms of cell death inhibition by
GRP78 involves blocking caspase activation. Our ¢ndings
suggest that GRP78 inhibits apoptotic signals at least in
part by blocking caspase activation.
2. Materials and methods
2.1. Plasmids, cells and culture conditions
The PstI/SspI fragment of hamster GRP78 (gift of Dr. Amy S. Lee)
containing the complete coding sequence was subcloned into the par-
ent vector, pTR-UF12, at the NsiI/EcoRV restrictions sites. This pla-
ces GRP78 under the control of a hybrid CMV enhancer/L-actin
promoter, followed by an internal ribosomal entry sequence and the
cDNA for enhanced green £uorescent protein. The cassette is £anked
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by the adeno-associated virus 145 bp inverted terminal repeats in a
pBS (Stratagene) backbone. The pTR-UF12 plasmid was a gift from
Dr. Barry Byrne, University of Florida Gene Therapy Center. Mouse
caspase-12 cDNA was ampli¢ed as previously described [16]. The
human embryonic kidney 293T cell line was used for transient trans-
fection as described earlier [16].
2.2. Immuno£uorescence staining
The human embryonic kidney 293T cells grown in poly-D-lysine-
coated culture slides (Becton Dickinson Labware, Bedford, MA,
USA) were washed with phosphate-bu¡ered saline and ¢xed with
4% paraformaldehyde in phosphate-bu¡ered saline for 20 min. For
the detection of GRP78, cells were stained with rabbit polyclonal anti-
GRP78 antibody (1:100 dilution, Santa Cruz Biotechnology) as pri-
mary antibody and Cy3-labeled donkey anti-rabbit IgG (1:400 dilu-
tion, Jackson Immunoresearch Labs) as the secondary antibody. The
rabbit polyclonal anti-GRP78 antibody that recognizes only GRP78
has previously been employed to determine the localization of the
surfactant protein B [17]. Nuclei were counterstained with 0.05%
DAPI (Sigma) in 1UTBS and washed for 30 min in three changes
of 1UTBS. Stained cells were examined using a Nikon Eclipse-800
epi£uorescence microscope equipped with appropriate ¢lters and the
images captured with a Magna¢re CCD color camera (Optronics,
Goleta, CA, USA) using PCI-Imaging software.
2.3. Cell-free extracts and Western blotting
Recombinant hamster GRP78 in 37 mM Tris^HCl pH 7.5/37 mM
NaCl was obtained from Stressgen Biotechnologies. Cell-free cyto-
plasmic extracts were prepared as previously described [18]. Electro-
phoresis and Western blot analysis were carried out as described ear-
lier [16]. Blots were probed with a 1:1000 dilution of the anti-GRP78
polyclonal antibody from Stressgen (Victoria, Canada), a 1:1000 di-
lution of the anti-caspase-3 monoclonal antibody, 1:500 dilution of
anti-caspase-7 monoclonal antibody (all from Transduction/Pharmin-
gen Laboratories, San Diego, CA, USA), and a 1:50 dilution of rat
monoclonal anti-caspase-12 antibody (gift of Dr. Junying Yuan). The
blots were incubated in a horseradish peroxidase-coupled secondary
antibody for 1 h followed by enhanced chemiluminescence detection
of the proteins with Hyper¢lm ECL detection (Amersham, Arlington
Heights, IL, USA).
2.4. Co-immunoprecipitation (co-IP) assay
Cell lysis and IP were performed as previously described [16,19,20]
to provide a qualitative assessment of caspase interaction before and
after ER stress. In a typical IP experiment we loaded 2.5-fold more
starting protein in the IP lane compared to the lysate lane. The pres-
ence of the interacting protein was detected by Western blot analysis
using the respective antibody.
2.5. Cell fractionation and limited tryptic digestion of
microsomal proteins
Fractionation was performed as described earlier [16,21]. The purity
of each fraction was assessed by the presence of speci¢c marker pro-
teins: poly(ADP-ribose) polymerase (PARP) for nuclei, protein disul-
¢de isomerase (PDI) and SREBP-1 for ER. Equal amounts of protein
were analyzed by electrophoresis. Isolated microsomes from normal
and treated cells were incubated with 0.05% trypsin-EDTA for 30 min
at 35‡C. At the end of the reaction, samples were detected by Western
blotting by loading equal amounts of total microsomal protein.
2.6. Quanti¢cation of apoptosis
Control and treated cells were stained with Hoechst 33258 and
quanti¢ed as previously described [18,22].
3. Results
3.1. ER stress-induced cell-free extracts fail to activate
caspases
Our initial studies examined the e¡ects of agents that induce
Fig. 1. ER stress-induced cell-free extracts fail to activate caspases. a: Cell-free cytosolic extracts (150 Wg protein) from untreated, 2.5 WM bre-
feldin-A- (24 h) and 2.5 WM thapsigargin-treated 293T cells were analyzed by Western blot analysis for GRP78. b: Cell-free cytosolic extracts
from untreated, 5 WM TMX- (24 h) and 2.5 WM brefeldin-A- (24 h) treated 293T cells were incubated for 1 h at 37‡C with various concentra-
tions of cytochrome c. Samples were analyzed by Western blot analysis for the pro- (32 kDa) and active forms of caspase-3 (20 and 18 kDa).
c: Cleavage of caspase-3 was also studied in cell-free extracts that were incubated with a ¢xed concentration of cytochrome c and varying
amounts of dATP. Figures are representative of three independent experiments.
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ER stress in order to understand the mechanism of cell death
in cell-free post-nuclear extracts. Brefeldin-A, a fungal metab-
olite, and thapsigargin, an inhibitor of the ER Ca-ATPase,
induce ER stress and cell death in many cell types [1,3,16]. A
high level of GRP78 protein expression is indicative of ER
stress [5^8] and accordingly cell-free extracts prepared from
cells treated with 2.5 WM brefeldin-A or 2.5 WM thapsigargin
displayed increased GRP78 protein expression (Fig. 1a). Ad-
dition of cytochrome c alone or together with dATP to post-
nuclear extracts initiates proteolysis of caspases and caspase
substrates characteristic of apoptosis [18,23]. As shown in Fig.
1b, addition of cytochrome c alone or together with dATP to
cell-free extracts from control (vehicle-treated) and tamoxifen
(TMX)-treated 293T cells induced caspase-3 processing (Fig.
1b,c). However, cell-free extracts from brefeldin-treated 293T
cells, which displayed increased GRP78 protein expression
(Fig. 1a), failed to cleave caspase-3 in the presence of various
concentrations of cytochrome c (Fig. 1b), and cleavage was
seen only when dATP was added together with cytochrome c
(Fig. 1c). Similar inhibition of caspase processing was also
seen in cell-free extracts made from thapsigargin cells (data
not shown).
The cell extract from brefeldin-treated 293T cells was par-
tially puri¢ed through a Sephadex G-50 column and the frac-
tion that displayed peak GRP78 protein expression was im-
munoprecipitated with anti-GRP78 antibody. The
supernatant obtained was added to a normal cell-free extract
in the presence of cytochrome c. A successful immunodeple-
tion of GRP78 from the extracts was achieved with the rabbit
polyclonal anti-GRP78 antibody (data not shown). As shown
in Fig. 2a (lane 3), the supernatant that had been immunode-
pleted of GRP78 protein failed to inhibit caspase-3 process-
ing, suggesting that the GRP78 present in the partially puri-
¢ed fraction is required for the inhibition of caspase cleavage.
To con¢rm that GRP78 directly inhibits caspase processing,
various concentrations of recombinant puri¢ed GRP78 were
added to untreated cell-free extracts. While 3 WM GRP78 did
not inhibit cytochrome c-mediated caspase-3 cleavage, addi-
tion of 4.9 WM GRP78 resulted in inhibition of caspase-3
cleavage as evidenced by an increase in the caspase-3 proform
Fig. 2. GRP78 inhibits caspase processing. Cell-free extract from 2.5 WM brefeldin-treated 293T cells was passed through a Sephadex G-50 col-
umn and fractions were collected. a: Fraction 4 (100 Wg) which showed a high GRP78 expression was immunoprecipitated with anti-GRP78
antibody. The supernatant obtained was added to a normal cell-free extract in the presence of cytochrome c. Samples were analyzed by West-
ern blot analysis for the pro- (32 kDa) and active forms of caspase-3 (20 and 18 kDa). b: Cell-free extracts from 293T cells were incubated
with 10 WM cytochrome c in the presence of recombinant GRP78 (3^4.9 WM), or similar amounts of the bu¡er in which GRP78 was reconsti-
tuted. Samples were analyzed by Western blot analysis for the pro- (32 kDa) and active forms of caspase-3 (20 and 18 kDa). Figures are repre-
sentative of three independent experiments.
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(Fig. 2b). We did not observe complete block of caspase-3
activation by rGRP78, since the high salt bu¡er in which
the recombinant protein was reconstituted (37 mM Tris^
HCl pH 7.5/37 mM NaCl) itself showed inhibitory properties
at higher concentrations.
3.2. Induction and localization of GRP78 protein in
ER stress-induced cells
GRP78 often serves as a marker protein for ER, and ac-
cordingly immunostaining demonstrated its faint perinuclear
expression in untreated cells (Fig. 3a). After treatment with
2.5 WM thapsigargin for 12 h, GRP78 staining became more
intense, appeared granular predominantly in the ER (Fig. 3b)
and also displayed a di¡use distribution throughout the cyto-
plasm. Virtually no co-localization of GRP78 and GM130 (a
Golgi marker protein) occurred under control or treated con-
ditions (data not shown). To determine the subcellular local-
ization of GRP78 before and after ER stress induction, cell
lysates from control, thapsigargin- (24 h) and brefeldin-A-
treated (24 h) 293T cells were fractionated into nuclear, micro-
somal and soluble fractions and analyzed by Western blotting.
The quality of the fractionation experiments was controlled by
assessing the distribution of standard marker proteins. As
shown in Fig. 3c, GRP78 protein expression was low and
predominantly localized in the microsomal fraction in control
extracts. Some expression was also seen in the nuclear frac-
tion. Following thapsigargin and brefeldin treatment, an in-
duction in GRP78 protein expression was detected in all three
fractions analyzed. This suggests that ER stress induction
causes a redistribution of GRP78 into the soluble fraction
(and possibly into the nuclear fraction, as well).
GRP78 within the ER lumen would not be expected to be
susceptible to trypsin digestion (in the absence of detergent).
In order to elucidate further the localization and topology of
GRP78 in the ER compartment after ER stress, we subjected
the microsomal fraction from control, brefeldin-A- and thap-
sigargin-treated 293T cells to limited trypsin digestion. As
shown in Fig. 3d, addition of trypsin resulted in partial diges-
tion of GRP78, with several tryptic fragments arising from the
digestion. Trypsin treatment was however su⁄cient to digest
caspase-12 completely (Fig. 3d). These data indicate that while
GRP78 normally resides primarily within the lumen of the
ER, ER stress can cause a subpopulation of GRP78 to exist
as a partially protease resistant (presumably transmembrane)
protein, and redistribute to the cytoplasmic fraction, as well.
Our results do not exclude the possibility that GRP78 appear-
ance in the cytosol and at the ER^cytosolic interface may also
re£ect upregulation without true redistribution. In either case,
the cytoplasmic pool of GRP78 or a subpopulation of GRP78
existing as an ER transmembrane protein could conceivably
prevent caspase activation and release.
3.3. Expression of GRP78 blocks caspase cleavage and
cell death
In order to demonstrate further the role of GRP78 in in-
hibiting caspase processing, 293T cells were transfected with a
hamster grp78 expression construct. There was a time-depen-
dent increase in the expression of GRP78 following transfec-
tion (data not shown). Since the di¡erence in GRP78 expres-
sion between control vector and GRP78 cDNA was greatest
at 18^24 h after transfection, further studies were carried out
at this time point. Cells were harvested 24 h after pGRP78
transfection and cytoplasmic extracts were prepared. Cleavage
of caspase-3, detected by the characteristic procaspase pro-
cessing from zymogen to active protease (Fig. 4a), occurred
in mock-transfected cell extracts (m) incubated with cyto-
chrome c, either alone or together with dATP. In contrast,
cleavage of caspase-3 in cell-free extracts from GRP78-trans-
fected cells (t) did not occur with cytochrome c, instead re-
quiring both cytochrome c and dATP. While ATP could also
reverse the inhibitory e¡ects of GRP78 (data not shown),
Fig. 3. Expression and localization of GRP78 before and after ER
stress. Double immuno£uorescent staining for GRP78 before (a)
and after ER stress (b) with Cy3 in 293T cells left in control me-
dium for 12 h before ¢xation in bu¡ered 4% paraformaldehyde. For
the detection of GRP78, cells were stained with rabbit polyclonal
anti-GRP78 antibody as primary antibody and Cy3-labeled donkey
anti-rabbit IgG as the secondary antibody. Nuclei are counter-
stained using VectaShield0 Mounting Medium with DAPI (Vector
Laboratories, Burlingame, CA, USA). c: Western blots of nuclear
(N), cytoplasmic (S) and microsomal (ER) fractions of 293T human
renal epithelial cells before and after treatment with 2.5 WM brefel-
din-A or 2.5 WM thapsigargin for 24 h. Cellular fractions were also
probed for standard marker proteins namely PARP (nuclei), PDI
and SREBP-1 (ER). d: Tryptic cleavage of GRP78 in isolated mi-
crosomes. Microsomes isolated from control, thapsigargin- (thaps)
and brefeldin-A-treated cell extracts were digested by 0.05% trypsin-
EDTA for 30 min at 35‡C. At the end of the reaction, samples
were detected by Western blotting.
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dATP was slightly more e¡ective which may be due to the fact
that dATP is superior to ATP in activating caspase-9 (in
concert with cytochrome c and Apaf-1). It is noteworthy
that a recent study demonstrated that GRP94 binds ATP
and dATP with nearly equal a⁄nities [24]. In order to rule
out the possibility that GRP78 transfection induced the ex-
pression of other ER stress proteins that may have anti-apo-
ptotic actions, we determined the expression of PDI (an ER
lumen protein) and HSP70 (a cytoplasmic chaperone protein).
As shown in Fig. 4b, neither PDI nor HSP70 appeared ap-
preciably di¡erent in the GRP78-transfected extracts in com-
parison to mock-transfected extracts, suggesting that no sig-
ni¢cant changes in the expression of other stress proteins that
contribute to the anti-apoptotic activity had taken place.
We demonstrated previously that ER stress not only in-
duces the expression of caspase-12 but also causes transloca-
tion of cytoplasmic caspase-7 to the ER surface, and pro-
longed ER stress facilitates movement of active caspase-12
into the cytoplasm [16] and induces cell death. Since GRP78
blocks caspase activation, we reasoned that expression of
GRP78 should inhibit caspase-induced cell death. As shown
in Fig. 4c, co-transfection of caspase-7 and caspase-12 expres-
sion constructs resulted in increased cell death that was
blocked by GRP78. The inhibition of caspase-7 and -12-medi-
ated cell death by GRP78 was observed only for about 24 h
after transfection and was decreased at longer periods follow-
ing transfection. One possible explanation may be the suscep-
tibility of GRP78 to caspase digestion (Rao et al., unpub-
lished observations).
3.4. Association of GRP78, caspase-7 and caspase-12
Since GRP78 blocks caspase activation, co-IP experiments
were carried out to determine whether GRP78 interacts with
components of the apoptosome or with other caspases. IP of
GRP78 protein from lysates obtained from transient co-trans-
fections of a hamster GRP78 expression construct with other
apoptotic expression constructs did not reveal any association
with caspase-3, caspase-8, Apaf-1, or cytochrome c (Fig. 5a,b
and data not shown). However, caspase-7 was found to asso-
ciate with GRP78 (Fig. 5c). Similar association of GRP78 and
caspase-7 was also seen in cell extracts from thapsigargin- and
brefeldin-treated cells (data not shown). In order to determine
whether GRP78 interacted with caspase-12, cell lysates from
293T cells treated with 2.5 WM thapsigargin were immunopre-
cipitated (IP) with GRP78 polyclonal antibody, and immuno-
blotted (WB, Western blotting) with anti-caspase-12 mono-
clonal antibody. As shown in Fig. 5d, GRP78 co-
immunoprecipitated with caspase-12. In addition to the cas-
pase-12 zymogen band, activated caspase-12 (42 kDa) also co-
immunoprecipitated with GRP78 (Fig. 5d). This raises the
possibility that caspase-12 may undergo activation in the mul-
timeric complex [16] by autocatalysis or by the catalytic ac-
Fig. 4. Expression of GRP78 inhibits caspase activation and cell death. a: Cytochrome c (10 WM) and various concentrations of dATP were
added to cell-free cytosolic extracts (150 Wg protein) made from 293T cells transiently transfected with GRP78 cDNA (t) or the control vector
(m). Extracts were incubated at 37‡C for 1 h and then analyzed by Western blot analysis for the pro- and active forms of caspase-3 (p32 to
p20 and p18). b: Western blots of mock (m) and GRP78-transfected (t) cell extracts probed with antibodies speci¢c for PDI and HSP70.
c: 293T cells were transfected with a total of 3 Wg of DNA consisting of either empty vector (pcDNA3) alone, 0.5 Wg Flag-tagged pC7, 1 Wg
pC12, 0.5 Wg Flag-tagged pC7+1 Wg pC12, or 0.5 Wg Flag-tagged pC7+1 Wg pC12+1.5 Wg pGRP78. Surviving vs. apoptotic cells were quanti¢ed
after 24 h, as described in Section 2. Data (means þ S.E.M.) are from three independent experiments.
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tivity of caspase-7. Addition of ATP or dATP to cell lysates
prior to IP caused a reduction in binding of pro- and active
forms of caspase-12 to GRP78 (Fig. 5d and data not shown),
without a¡ecting the interaction of caspase-7 and GRP78
(Fig. 5c). Thus during ER stress, GRP78 forms a complex
with caspase-7 zymogen, caspase-12 zymogen, and caspase-
12 and controls activation of the caspase cascade, possibly
by preventing their release from this putative inhibitory com-
plex.
4. Discussion
While GRP78 exists as an ER lumen protein [3], several
reports have suggested that GRP78 and its mutant forms
may also be associated with cytosol, membrane and nuclear
fractions, as well as the cell surface [25^28]. Calreticulin, an
ER lumenal protein, also redistributes from the ER and ap-
pears in the cytosol during heat stress [29]. Similarly, a sub-
population of GRP94 associates with the ER membrane dur-
ing an apoptotic insult, where it becomes a target of calpain
activity [21]. Our studies suggest that ER stress leads to the
redistribution of GRP78 to the soluble fraction, with a sub-
population of GRP78 becoming partially protease resistant.
This e¡ect suggests that, under such conditions, GRP78 may
also exist as an ER transmembrane protein. Our data are also
compatible with the alternative explanation that GRP78 ap-
pearance in cytosol and at the ER^cytosolic interface may
re£ect upregulation without true redistribution. In either
case, however, this would result in the observed complex for-
mation between GRP78, caspase-7, and caspase-12. Either the
cytoplasmic pool of GRP78 or a subpopulation of GRP78
existing as an ER transmembrane protein could form a com-
plex with caspases-7 and -12 at the ER surface and prevent
their activation and release. Cells are believed to tolerate ER
stress insults up to 24 h due to the long half-life of ER stress
proteins [30], and in our experiments, control of ER stress-
induced cell death by GRP78 could be seen for up to 24 h
following treatment. With longer exposure to ER stress
agents, apoptosis and associated caspase activity were ob-
served. Prolonged ER stress, together with (d)ATP binding
to the complex, may either disrupt the multimeric complex
or render it more evanescent, ensuring the liberation of active
caspase-12 into the cytosol. Proteolytic cleavage of the cyto-
protective GRP78 by caspase-7 or caspase-12 during pro-
longed ER stress may also occur and could explain the break-
down of this complex and the liberation of active caspase-12.
Thus the GRP78^caspase-7^caspase-12 complex represents an
inhibitory analogue of the ‘apoptosome’ [31,32]. The apopto-
some includes caspase-9 zymogen, Apaf-1, cytochrome c, and
(d)ATP, and facilitates activation of caspase-9. In contrast,
GRP78 blocks caspases; however, (d)ATP is still pro-apopto-
tic, since it leads to dissociation of the GRP78/caspase-12
inhibitory complex.
Other ER stress proteins like PDI, ORP-150 and heat shock
Fig. 5. Interaction of GRP78, caspase-7 and caspase-12. Expression constructs of GRP78 together with caspase-3 (a), caspase-8 (b) or caspase-
7 (c) were transiently transfected into 293T cells. After 30 h, cells were lysed and the lysate was immunoprecipitated (IP) with anti-GRP78 rab-
bit antibody and immunoblotted (WB, Western blotting) with anti-caspase-3 (a), anti-caspase-8 (b) or anti-caspase-7 antibody (c). One set of
samples was treated with 1 mM ATP prior to IP. d: Cell lysate from 2.5 WM thapsigargin-treated 293T cells was immunoprecipitated (IP) with
anti-GRP78 rabbit antibody and immunoblotted (WB, Western blotting) with rat anti-caspase-12 monoclonal antibody. One set of samples was
treated with 1 mM ATP prior to IP. Both caspase-12 and the cross-reacting IgG heavy chain were separated on an 8% Tris^glycine gel. Di¡er-
ent exposures were used for the 60 kDa and processed (42 kDa) caspase-12. Figures are representative of two independent experiments.
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proteins including HSP27 and HSP70 are also known to have
anti-apoptotic activity, but their mechanisms are likely to be
di¡erent than that of GRP78 [33^37]. The current studies
highlight the importance of GRP78 as an anti-apoptotic pro-
tein, and shed new light on the mechanisms underlying the
relationship between ER stress, the UPR and the cell death
program. The results could have broad implications for our
understanding of the mechanism by which cells couple ER
stress to the cell death program, and the mechanism by which
the associated decision between apoptosis inhibition and acti-
vation is controlled.
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